Activated astrocytes enhance the dopaminergic differentiation of stem cells and promote brain repair through bFGF.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25517983.
- Also identified by DOI 10.1038/ncomms6627 and PMC identifier 4284631.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Astrocytes provide neuroprotective effects against degeneration of dopaminergic (DA) neurons and play a fundamental role in DA differentiation of neural stem cells. Here we show that light illumination of astrocytes expressing engineered channelrhodopsin variant (ChETA) can remarkably enhance the release of basic fibroblast growth factor (bFGF) and significantly promote the DA differentiation of human embryonic stem cells (hESCs) in vitro. Light activation of transplanted astrocytes in the substantia nigra (SN) also upregulates bFGF levels in vivo and promotes the regenerative effects of co-transplanted stem cells. Importantly, upregulation of bFGF levels, by specific light activation of endogenous astrocytes in the SN, enhances the DA differentiation of transplanted stem cells and promotes brain repair in a mouse model of Parkinson's disease (PD). Our study indicates that astrocyte-derived bFGF is required for regulation of DA differentiation of the stem cells and may provide a strategy targeting astrocytes for treatment of PD.
Medical subject headings
- Astrocytes
- Cell- and Tissue-Based Therapy
- Dopaminergic Neurons
- Fibroblast Growth Factor 2
- Parkinson Disease
- Stem Cell Transplantation